It's time to acknowledge access as a prescribing barrier

A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

By Karissa Waddick • May 11, 2022

FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

By Kelly Bilodeau • May 10, 2022

Explore the Trendline➔

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

By PharmaVoice staff

Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

By Taren Grom • May 9, 2022

Pharma's solution to the digital advertising dilemma? Storytelling

Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

By Karissa Waddick • May 5, 2022

From cancer survivor to clinical trial innovator

How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.

By Kelly Bilodeau • May 3, 2022

One company's failed drug is this company's 'jewel'

Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

By Meagan Parrish • May 2, 2022

Laura Randa's aim to break down mental healthcare barriers for disabled patients

Despite the proliferation of mental health apps, many aren’t accessible for people with disabilities. The CEO of Toivoa plans to change that.

By Alexandra Pecci • April 27, 2022

Woman of the Week: Gilead Science's Dr. Shanthi Ganeshan

As vice president of Global Regulatory Affairs, Oncology at Gilead, Ganeshan says there’s ‘never a dull moment’ in the quest to deliver therapies to patients.

By Taren Grom • April 27, 2022

Real-world data is making drug development more true to life

How RWD is moving from the background to the spotlight in pharma’s development process.

By Kelly Bilodeau • April 26, 2022

For Global Blood Therapeutics, the connection to sickle cell disease runs deep

An underserved patient population is a guiding light for the company, which recently scored a new approval.

By Robin Robinson • April 19, 2022

How pharma can up its social media game

Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities. 

By Karissa Waddick • April 18, 2022

Clinical content that meets the top 3 needs of HCPs

Learn how to meet the needs of HCPs with clinical content designed to be served up, save time, and satisfy curiosity.

By Rob Spalding is the Chief Strategy & Marketing Officer at Avant Healthcare • April 18, 2022

Inflation is forcing prioritization of healthcare spending — are you ready?

Inflation means your customers' money doesn't travel as far as it did a few weeks ago.

April 18, 2022

What now? Alzheimer's drugmakers ponder the path to approval

Why Medicare’s unprecedented decision to limit coverage for Aduhelm could have a chilling effect on Alzheimer’s R&D.

By Kelly Bilodeau • April 14, 2022

'Bootcamp' helps rare disease advocates learn the ropes of drug development

Ultragenyx’s CEO on why supporting others in rare diseases pays dividends all around.

By Kim Ribbink • April 12, 2022

Why the war in Ukraine could accelerate the deglobalization of clinical trials

COVID-19 slowed many studies — but the war could further strain clinical trials worldwide.

By Michael Gibney • April 12, 2022

Clinical trial recruitment hits the local pharmacy counter

CVS Health's partnership with clinical trial software company Medable is designed to make recruitment easier for patients and drug makers alike.

By Kelly Bilodeau • April 5, 2022

Down but not out: How AVEO's CEO steered the company past an FDA rejection

Michael Bailey explains why focusing on the patient helped AVEO clear regulatory hurdles to bring a new cancer drug across the finish line.

By Kim Ribbink • April 5, 2022

Time-saving tech lights Alcon's path into digital innovation

Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

By Kim Ribbink • April 4, 2022

From media to menopause: Creating new spaces in women's telehealth

Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

By Alexandra Pecci • March 29, 2022

How a rock 'n' roll guru is putting a new spin on health education for patients

A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.

By Meagan Parrish • March 28, 2022

Rare Patient Voice's president is striving to create a five-star experience for patients

Successful clinical trial recruitment depends on listening to and empowering patients.

By Kim Ribbink • March 23, 2022

Woman of the Week: Merck's Dr. Mary-Ann Etiebet

The associate VP of health equity is on a quest to address the relationship between health, gender and economic opportunities.

By Taren Grom • March 23, 2022

Why Astellas is adopting a 'focus area approach' to partnerships

Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.

By Kim Ribbink • March 22, 2022

BioMarin’s new global head of advocacy is tackling the holy grail of patient engagement

In her new role, Dr. Roz is keeping her patient-first approach.

By Taren Grom • March 21, 2022